Commentary
The recent security breach of 23andMe has prompted conservative groups to call for an amendment to the National Defense Authorization Act (NDAA) to break ties between the U.S. government and China-linked biotech firms.
BGI Group Laboratory technician working on samples from people to be tested for COVID-19 at "Fire Eye" laboratory in Wuhan, Hubei Province, China, on Feb. 6, 2020. STR/AFP via Getty Images
Antonio Graceffo
Author
Antonio Graceffo, Ph.D., is a China economy analyst who has spent more than 20 years in Asia. Graceffo is a graduate of the Shanghai University of Sport, holds an MBA from Shanghai Jiaotong University, and studied national security at American Military University.
